Treatment of Asthma: The long-acting beta-2-agonists
Other Authors: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Vienna
Springer Vienna
1998, 1998
|
Edition: | 1st ed. 1998 |
Subjects: | |
Online Access: | |
Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- Molecular regulation of the ?2-adrenergic receptor by long- and short-acting ?-agonists
- Molecular interactions between glucocorticoids and ?2-agonists
- Formoterol, a new long-acting ?2-agonist
- Development of the long-acting ?2-agonist, salmeterol
- Development of bambuterol; a long acting, orally active beta-agonist prodrug
- Development of ?2-receptors in infancy and childhood
- Long-acting beta-agonists in exercise induced asthma
- Salmeterol and oral steroid treatment
- Salmeterol and its relationship to treatment with inhaled corticosteroids
- Long term treatment with formoterol
- Comparison of efficiency of bambuterol and salmeterol
- The future of relievers and controllers in asthma therapy